Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
George G. Zhanel, Alyssa Golden, Sheryl Zelenitsky, et al.
Drugs (2019) Vol. 79, Iss. 3, pp. 271-289
Closed Access | Times Cited: 349

Showing 1-25 of 349 citing articles:

Antimicrobial Resistance in ESKAPE Pathogens
David M. P. De Oliveira, Brian M. Forde, Timothy J. Kidd, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 3
Open Access | Times Cited: 1521
New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives
Marco Terreni, Marina Taccani, Massimo Pregnolato
Molecules (2021) Vol. 26, Iss. 9, pp. 2671-2671
Open Access | Times Cited: 399
Nutritional immunity: the battle for nutrient metals at the host–pathogen interface
Caitlin C. Murdoch, Eric P. Skaar
Nature Reviews Microbiology (2022) Vol. 20, Iss. 11, pp. 657-670
Open Access | Times Cited: 339
Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin
Takafumi Sato, Kenji Yamawaki
Clinical Infectious Diseases (2019) Vol. 69, Iss. Supplement_7, pp. S538-S543
Open Access | Times Cited: 253
Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter
Sameer Dhingra, Nor Azlina A. Rahman, Ed Peile, et al.
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 248
In Vitro Activity of Cefiderocol Against a Broad Range of Clinically Important Gram-negative Bacteria
Yoshinori Yamano
Clinical Infectious Diseases (2019) Vol. 69, Iss. Supplement_7, pp. S544-S551
Open Access | Times Cited: 163
Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design
Guillermo Bahr, Lisandro J. González, Alejandro J. Vila
Chemical Reviews (2021) Vol. 121, Iss. 13, pp. 7957-8094
Open Access | Times Cited: 158
Crossroads of Antibiotic Resistance and Biosynthesis
Timothy A. Wencewicz
Journal of Molecular Biology (2019) Vol. 431, Iss. 18, pp. 3370-3399
Open Access | Times Cited: 152
Thiazoles, Their Benzofused Systems, and Thiazolidinone Derivatives: Versatile and Promising Tools to Combat Antibiotic Resistance
Stella Cascioferro, Barbara Parrino, Daniela Carbone, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 15, pp. 7923-7956
Open Access | Times Cited: 152
Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
Janet Wu, Pavithra Srinivas, Jason M. Pogue
Infectious Diseases and Therapy (2020) Vol. 9, Iss. 1, pp. 17-40
Open Access | Times Cited: 150
Carbapenem-Resistant Klebsiella pneumoniae: Virulence Factors, Molecular Epidemiology and Latest Updates in Treatment Options
Theodoros Karampatakis, Katerina Tsergouli, Payam Behzadi
Antibiotics (2023) Vol. 12, Iss. 2, pp. 234-234
Open Access | Times Cited: 143
Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Stephen Wood, Timothy M. Kuzel, Sasha H. Shafikhani
Cells (2023) Vol. 12, Iss. 1, pp. 199-199
Open Access | Times Cited: 129
Management of bacterial and fungal infections in cirrhosis: The MDRO challenge
Javier Fernández, Salvatore Piano, Michele Bartoletti, et al.
Journal of Hepatology (2021) Vol. 75, pp. S101-S117
Open Access | Times Cited: 124
Genome mining methods to discover bioactive natural products
Katherine D. Bauman, Keelie S. Butler, Bradley S. Moore, et al.
Natural Product Reports (2021) Vol. 38, Iss. 11, pp. 2100-2129
Open Access | Times Cited: 115
Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections
Souha S. Kanj, Matteo Bassetti, Pattarachai Kiratisin, et al.
International Journal of Antimicrobial Agents (2022) Vol. 60, Iss. 3, pp. 106633-106633
Open Access | Times Cited: 85
An Overview of Antimicrobial Stewardship Optimization: The Use of Antibiotics in Humans and Animals to Prevent Resistance
Md. Mominur Rahman, Mst. Afroza Alam Tumpa, Mehrukh Zehravi, et al.
Antibiotics (2022) Vol. 11, Iss. 5, pp. 667-667
Open Access | Times Cited: 74
Tackling the outer membrane: facilitating compound entry into Gram-negative bacterial pathogens
Deepanshi Saxena, Rahul Maitra, Rakhi Bormon, et al.
npj Antimicrobials and Resistance (2023) Vol. 1, Iss. 1
Open Access | Times Cited: 51
Intrinsic antimicrobial resistance: Molecular biomaterials to combat microbial biofilms and bacterial persisters
Swagatam Barman, Leman Buzoglu Kurnaz, Ryan Leighton, et al.
Biomaterials (2024) Vol. 311, pp. 122690-122690
Closed Access | Times Cited: 20
Cefiderocol either in monotherapy or combination versus best available therapy in the treatment of carbapenem-resistant Acinetobacter baumannii infections: A systematic review and meta-analysis
Lorenzo Onorato, Ilaria de Luca, Caterina Monari, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106113-106113
Open Access | Times Cited: 18
Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents
Mazen S. Bader, Mark Loeb, Daniela Leto, et al.
Postgraduate Medicine (2019) Vol. 132, Iss. 3, pp. 234-250
Closed Access | Times Cited: 141
Carbapenemases in Enterobacteriaceae: Detection and Antimicrobial Therapy
Xiaoyan Cui, Haifang Zhang, Hong Du
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 131
Siderophore–Antibiotic Conjugate Design: New Drugs for Bad Bugs?
Kokob H. Negash, James K.S. Norris, James T. Hodgkinson
Molecules (2019) Vol. 24, Iss. 18, pp. 3314-3314
Open Access | Times Cited: 124
Molecular Mechanisms, Epidemiology, and Clinical Importance of β-Lactam Resistance in Enterobacteriaceae
Giulia De Angelis, Paola Del Giacomo, Brunella Posteraro, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5090-5090
Open Access | Times Cited: 119
Cefiderocol Antimicrobial Susceptibility Testing Considerations: the Achilles' Heel of the Trojan Horse?
Patricia J. Simner, Robin Patel
Journal of Clinical Microbiology (2020) Vol. 59, Iss. 1
Open Access | Times Cited: 116
Iron Acquisition Systems of Gram-negative Bacterial Pathogens Define TonB-Dependent Pathways to Novel Antibiotics
Phillip E. Klebba, Salete M. Newton, David A. Six, et al.
Chemical Reviews (2021) Vol. 121, Iss. 9, pp. 5193-5239
Open Access | Times Cited: 97
Page 1 - Next Page

Scroll to top